全文获取类型
收费全文 | 820篇 |
免费 | 35篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 16篇 |
妇产科学 | 17篇 |
基础医学 | 69篇 |
口腔科学 | 3篇 |
临床医学 | 47篇 |
内科学 | 157篇 |
皮肤病学 | 10篇 |
神经病学 | 27篇 |
特种医学 | 132篇 |
外科学 | 171篇 |
综合类 | 6篇 |
一般理论 | 1篇 |
预防医学 | 40篇 |
眼科学 | 33篇 |
药学 | 44篇 |
中国医学 | 10篇 |
肿瘤学 | 64篇 |
出版年
2023年 | 2篇 |
2022年 | 7篇 |
2021年 | 21篇 |
2020年 | 9篇 |
2019年 | 9篇 |
2018年 | 21篇 |
2017年 | 16篇 |
2016年 | 16篇 |
2015年 | 12篇 |
2014年 | 23篇 |
2013年 | 45篇 |
2012年 | 45篇 |
2011年 | 63篇 |
2010年 | 48篇 |
2009年 | 40篇 |
2008年 | 67篇 |
2007年 | 88篇 |
2006年 | 64篇 |
2005年 | 51篇 |
2004年 | 36篇 |
2003年 | 44篇 |
2002年 | 48篇 |
2001年 | 10篇 |
2000年 | 5篇 |
1999年 | 7篇 |
1998年 | 7篇 |
1997年 | 2篇 |
1996年 | 5篇 |
1995年 | 1篇 |
1994年 | 2篇 |
1993年 | 2篇 |
1992年 | 4篇 |
1991年 | 10篇 |
1990年 | 3篇 |
1989年 | 2篇 |
1988年 | 2篇 |
1987年 | 8篇 |
1986年 | 2篇 |
1983年 | 2篇 |
1981年 | 3篇 |
1977年 | 5篇 |
1976年 | 1篇 |
1975年 | 1篇 |
1974年 | 1篇 |
1968年 | 1篇 |
1967年 | 1篇 |
1966年 | 1篇 |
1965年 | 1篇 |
1962年 | 1篇 |
排序方式: 共有865条查询结果,搜索用时 31 毫秒
11.
12.
Antoniak S Boltzen U Riad A Kallwellis-Opara A Rohde M Dörner A Tschöpe C Noutsias M Pauschinger M Schultheiss HP Rauch U 《Journal of molecular and cellular cardiology》2008,45(1):118-126
We investigated the effects of viral infection on Tissue Factor (TF) expression and activity in mice within the myocardium to understand increased thrombosis during myocarditis. Mice were infected with coxsackie virus B3 (CVB3) and the hearts were collected at day 4, 8 and 28 post infection (p.i.). Myocardial TF expression and cellular activity as well as plasma activity were analyzed from CVB3 infected mice by Western blot, chromogenic Factor Xa generation assay, in situ staining for active TF and immunohistochemistry. In addition to TF expression, hemodynamic parameters were measured during the time course of infection. Furthermore, we analyzed myocardial tissues from patients with suspected inflammatory cardiomyopathy. TF protein expression was maximally 5-fold elevated 8 days p.i. in mice and remained increased on day 28 p.i. (P < 0.001 vs. non-infected controls). Alterations in TF expression were associated with fibrin deposits within the myocardium. The TF pathway inhibitor protein expression in the myocardium was not altered during myocarditis. Active cellular TF co-localized with CD3 positive cells and VCAM-1 positive endothelial cells in the myocardium. The TF expression was positively correlated with the amount of infiltrating CD3 and Mac3 positive cells (Spearman-Rho ρ = 0.749 P < 0.0001 for CD3+ and ρ = 0.775 P < 0.0001 for Mac3+; N = 35). Increased myocardial TF expression was associated with a 2-fold elevated plasma activity (P < 0.05 vs. non-infected controls). In the human hearts, the TF expression correlated postively with an endothelial cell activation marker (ρ = 0.523 P < 0.0001 for CD62E; N = 54). Viral myocarditis is a hypercoagulative state which is associated with increased myocardial TF expression and activity. Upregulation of TF contributes to a systemic activation of the coagulation cascade. 相似文献
13.
14.
15.
16.
Free functioning gracilis transplantation for reconstruction of elbow and hand functions in late obstetric brachial plexus palsy
下载免费PDF全文
![点击此处可从《Microsurgery》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Tarek A. El‐Gammal M.D. Amr El‐Sayed M.D. Mohamed M. Kotb M.D. Waleed Riad Saleh M.D. Yasser Farouk Ragheb M.D. Omar Refai M.D. Mohamed Mohamed Morsy M.D. 《Microsurgery》2015,35(5):350-355
Background: In late obstetric brachial plexus palsy (OBPP), restoration of elbow and hand functions is a difficult challenge. The use of free functioning muscle transplantation in late OBPP was very scarcely reported. In this study, we present our experience on the use of free functioning gracilis transfer for restoration of elbow and hand functions in late cases of OBPP. Patients and Methods: Eighteen patients with late OBPP underwent free gracilis transfer for reconstruction of elbow and/or hand functions. The procedure was indicated when there was no evidence of reinnervation on EMG and in the absence of local donors. Average age at surgery was 102.5 months. Patients were evaluated using the British Medical Research Council (MRC) grading system and the Toronto Active Movement Scale. Hand function was evaluated by the Raimondi scoring system. Results: The average follow‐up was 65.8 ± 41.7 months. Contraction of the transferred gracilis started at an average of 4.5 ± 1.03 months. Average range of elbow flexion significantly improved from 30 ± 55.7 to 104 ± 31.6 degrees (P <0.001). Elbow flexion power significantly increased with an average of 3.8 grades (P = 0.000147). Passive elbow range of motion significantly decreased from an average of 147 to 117 degrees (P = 0.003). Active finger flexion significantly improved from 5 ± 8.3 to 63 ± 39.9 degrees (P < 0.001). Finger flexion power significantly increased with an average 2.7 grades (P < 0.001). Only 17% achieved useful hand (grade 3) on Raimondi hand score. Triceps reconstruction resulted in an average of M4 power and 45 degrees elbow extension. Conclusion: Free gracilis transfer may be a useful option for reconstruction of elbow and/or hand functions in late OBPP. © 2015 Wiley Periodicals, Inc. Microsurgery 35:350–355, 2015. 相似文献
17.
18.
Senthilnathan S Memon K Lewandowski RJ Kulik L Mulcahy MF Riaz A Miller FH Yaghmai V Nikolaidis P Wang E Baker T Abecassis M Benson AB Omary RA Salem R 《Hepatology (Baltimore, Md.)》2012,55(5):1432-1442
Although most cancers are considered predominantly systemic processes, this may not hold true for hepatocellular carcinoma (HCC). The literature regarding patterns of progression of HCC (local versus systemic) has been relatively sparse. Our objectives were to: (1) analyze patterns of progression in HCC patients presenting with intrahepatic disease from initial treatment until death, and (2) identify clinically relevant risk factors for the development of metastases. Over a 9-year period, 285 patients treated with transarterial locoregional therapies underwent scheduled imaging follow-up from treatment until death and were categorized by pattern of progression: (i) intrahepatic (increased tumor enhancement/size, development/progression of vascular invasion, new hepatic lesions) progression or (ii) extrahepatic (adrenal/bone/lung/lymph node) metastases. Uni/multivariate analyses assessing the risk factors for the development of metastases were performed. The median time from last scan to death was 2.4 months (interquartile range: 1.3-4.8 months). The time to development of metastases, vascular invasion, and/or new lesions was 13.8 months (confidence interval: 11.3-17.7 months). Of the 209 patients followed until death, only 50 developed extrahepatic metastases (24%). Multivariate analyses identified age <65 years (P = 0.038), alpha-fetoprotein >200 ng/mL (P = 0.04), and vascular invasion (P = 0.017) as significant predictors of metastases development. CONCLUSION: Knowledge of the risk factors associated with the development of metastases may help guide assessment of patient prognosis. Because 76% of patients presenting with local disease treated with locoregional therapies die without developing extrahepatic metastases, the notion of HCC as a systemic disease, as detected by imaging, may be reconsidered. 相似文献
19.
Ajay K. Israni Samy M. Riad Robert Leduc William S. Oetting Weihua Guan David Schladt Arthur J. Matas Pamala A. Jacobson DeKAF Genomics Investigators 《Transplant international》2013,26(10):982-989
Most calcineurin inhibitor (CNI)‐based protocols reduce blood trough goals approximately 2–3 months post‐transplant in clinically stable kidney transplant recipients. The CNI target trough level to prevent rejection, after reduction, is unknown. Using a multivariate Cox proportional hazards model, we determined the association of time‐varying tacrolimus (TAC) trough levels with acute rejection (AR) occurring in the first 6 months post‐transplant, but specifically we assessed this association after 3 months. A total of 1930 patients received TAC‐based immunosuppression prior to AR in a prospective study. Of the 151 (7.8%) who developed AR, 47 developed AR after 3 months post‐transplant. In an adjusted time‐varying multivariate model, each 1 ng/ml decrease in TAC trough levels was associated with a 7.2% increased risk of AR [hazards ratio (HR) = 1.07, 95% confidence interval (CI) (1.01, 1.14) P = 0.03] in the first 6 months. There was an additional 23% increased risk of AR with each 1 ng/ml decrease in the TAC trough levels in months 3–6 [HR = 1.23, 95% CI (1.06, 1.43) P = 0.008]. In conclusion, lower TAC trough levels were significantly associated with increased risk of AR in the first 6 months post‐transplant with additional risk of AR between months 3 and 6 post‐transplant. The timing and practice of TAC dose reduction should be personalized based on the individual's risk factors. 相似文献
20.
Ahmed Gabr Joseph Ralph Kallini Vanessa L. Gates Ryan Hickey Laura Kulik Kush Desai Bartley Thornburg Karen Marshall Krystina Salzig Melissa Williams Carlene del Castillo Daniel Ganger Elias Hohlastos Talia Baker Robert J. Lewandowski Riad Salem 《European journal of nuclear medicine and molecular imaging》2016,43(13):2353-2359